From: The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
Phase
Period
Frequency of administration
Dose
Induction
First month
2 times/week
56Â mg
Maintenance
Second month
1 time/week
Third month and longer
1 time/2Â weeks